[1]
|
N. Gaddam and J. Aukunuru, “Systemic Delivery of Diclofenac Sodium after Topical Application of Gels Incorporated with Drug-Loaded Solid Lipid Nanoparticles (SLN),” Journal of Pharmaceutical Health Services Research, Vol. 2, No. 2, 2010, pp. 177-187.
|
[2]
|
K. M. Manjanna, B. Shivakumar and T. M. P. Kumar, “Diclofenac Sodium Microbeads for Oral Sustained Drug Delivery,” International Journal of PharmTech Research, Vol. 1, No. 2, 2009, pp. 317-327.
|
[3]
|
A. Chiarini, A. Tartarini and A. Fini, “pH-Solubility Relationship and Partition Coefficients for Some Anti-In-flammatory Arylaliphatic Acids,” Archiv der Pharmazie, Vol. 317, No. 3, 1984, pp. 268-273.
doi:10.1002/ardp.19843170314
|
[4]
|
A. S. Bravo, M. C. Lamas and C. J. Salomón, “In-Vitro Studies of Diclofenac Sodium Controlled-Release from Biopolymeric Hydrophilic Matrices,” Journal of Pharmaceutical Sciences, Vol. 5, No. 3, 2002, pp. 213-219.
|
[5]
|
M. Bartolomei, P. Bertocchi, E. Antoniella and A. Rodomonte, “Physico-Chemical Characterisation and Intrinsic Dissolution Studies of a New Hydrate form of Diclofenac Sodium: Comparison with Anhydrous Form,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 40, No. 5, 2006, pp. 1105-1113. doi:10.1016/j.jpba.2005.09.009
|
[6]
|
B. M. Al-Taani and B. M. Tashtoush, “Effect of Microenvironment pH of Swellable and Erodable Buffered Matrices on the Release Characteristics of Diclofenac Sodium,” AAPS PharmSciTech, Vol. 4, 2003, pp. 110-115.
doi:10.1208/pt040343
|
[7]
|
S. L. Collins, R. A. Moore, H. J. McQuay and P. J. Wiffen, “Oral Ibuprofen and Diclofenac in Post-Operative Pain: A Quantitative Systematic Review,” European Journal of Pain, Vol. 2, No. 4, 1998, pp. 285-291.
|
[8]
|
J. Schwaiger, H. Ferling, U. Mallow, H. Wintermayr and R. D. Negele, “Toxic Effects of the Non-Steroidal Anti-Inflammatory Drug Diclofenac. Part I: Histopathological Alterations and Bioaccumulation in Rainbow Trout,” Aquatic Toxicology, Vol. 68, No. 2, 2004, pp. 141-150.
doi:10.1016/j.aquatox.2004.03.014
|
[9]
|
E. J. Hickey, R. R. Raje, V. E. Reid, S. M. Gross and S. D. Ray, “Diclofenac Induced in Vivo Nephrotoxicity May Involve Oxidative Stress-Mediated Massive Genomic DNA Fragmentation and Apoptotic Cell Death,” Free Radical Biology and Medicine, Vol. 31, No. 2, 2001, pp. 139-152. doi:10.1016/S0891-5849(01)00560-3
|
[10]
|
C. C. Kao, S. C. Chen and M. T. Sheu, “Lag Time Method to Delay Drug Release to Various Sites in the Gastrointestinal Tract,” Journal of Controlled Release, Vol. 44, No. 2-3, 1997, pp. 263-270.
doi:10.1016/S0168-3659(96)01529-5
|
[11]
|
C. Barbé, J. Bartlett, L. Kong, K. Finnie, H. Q. Lin, M. Larkin, S. Calleja, A. Bush and G. Calleja, “Silica Particles: A Novel Drug-Delivery System,” Advanced Materials, Vol. 16, No. 21, 2004, pp. 1959-1966.
doi:10.1002/adma.200400771
|
[12]
|
Y. Zhou and X. Y. Wu, “Finite Element Analysis of Diffusional Drug Release from Complex Matrix Systems. I. Complex Geometries and Composite Structures,” Journal of Controlled Release, Vol. 49, No. 2-3, 1997, pp. 277 288.
doi:10.1016/S0168-3659(97)00103-X
|
[13]
|
S. W. Song, K. Hidajat and S. Kawi, “Functionalized SBA-15 Materials as Carriers for Controlled Drug Delivery: Influence of Surface Properties on Matrix-Drug Interactions,” Langmuir, Vol. 21, No. 21, 2005, pp. 9568-9575. doi:10.1021/la051167e
|
[14]
|
W. J. Xu, Q. Gao, Y. Xu, D. Wu, Y. H. Sun, W. L. Shen and F. Deng, “Controlled Drug Release from Bifunctionalized Mesoporous Silica,” Journal of Solid State Chemistry, Vol. 181, No. 10, 2008, pp. 2837 2844.
doi:10.1016/j.jssc.2008.07.011
|
[15]
|
M. Manzano, V. Aina, C. O. Arean, F. Balas, V. Cauda, M. Colilla, M. R. Delgado and M. Vallet-Regi, “Studies on MCM-41 Mesoporous Silica for Drug Delivery: Effect of Particle Morphology and Amine Functionalization,” Chemical Engineering Journal, Vol. 137, No. 1, 2008, pp. 30-37. doi:10.1016/j.cej.2007.07.078
|
[16]
|
M. Aw, S. Simovic, Y. Yu, J. Addai-Mensah and D. Losic, “Porous Silica Microshells from Diatoms as Biocarrier for Drug Delivery Applications,” Powder Technology, Vol. 223, 2012, pp. 52-58.
doi:10.1016/j.powtec.2011.04.023
|
[17]
|
M. D. Popova, á. Szegedi, I. N. Kolev, J. Mihály, B. S. Tzankov, G. T. Momekov, N. G. Lambov and K. P. Yoncheva, “Carboxylic Modified Spherical Mesoporous Silicas as Drug Delivery Carriers,” International Journal of Pharmaceutics, Vol. 436, No. 1-2, 2012, pp. 778-785.
doi:10.1016/j.ijpharm.2012.07.061
|
[18]
|
P. Kortesuo, M. Ahola, M. Kangas, I. Kangasniemi, A. Yli-Urpo and J. Kiesvaara, “In Vitro Evaluation of Sol-Gel Processed Spray Dried Silica Gel Microspheres as Carrier in Controlled Drug Delivery,” International Journal of Pharmaceutics, Vol. 200, No. 2, 2000, pp. 223-229. doi:10.1016/S0378-5173(00)00393-8
|
[19]
|
K. Czarnobaj, “Preparation and Characterization of Silica Xerogels as Carriers for Drugs,” Drug Delivery, Vol. 15, No. 8, 2008, pp. 485-492.
doi:10.1080/10717540802321495
|
[20]
|
R. Jayakumar, D. Menon, K. Manzoor, S. V. Nair and H. Tamura, “Biomedical Applications of Chitin Nanomaterials: A Short Review,” Carbohydrate Polymers, Vol. 82, No. 2, 2010, pp. 227-232.
doi:10.1016/j.carbpol.2010.04.074
|
[21]
|
E. Hodgson and J. A. Goldstein, “Metabolism of Toxicants: Phase I Reactions and Pharmacogenetics,” In: E. Hodgson and R. C. Smart, Eds., Introduction to Biochemical Toxicology, 3rd Edition, Wiley-Interscience, New York, 2001, pp. 67-113.
|
[22]
|
L. S. Fonseca, R. P. Silveira, A. M. Deboni, E. V. Benvenutti, T. M. Costa, S. S. Guterres and A. R. Pohlmann, “Nanocapsule@xerogel Microparticles Containing Sodium Diclofenac: A New Strategy to Control the Release of Drugs,” International Journal of Pharmaceutics, Vol. 358, No. 1-2, 2008, pp. 292-295.
doi:10.1016/j.ijpharm.2008.02.005
|
[23]
|
E. J. Lee, S. H. Jun, H. E. Kim, H. W. Kim, Y. H. Koh and J. H. Jang, “Silica Xerogel-Chitosan Nano-Hybrids for Use as Drug Eluting Bone Replacement,” Journal of Materials Science: Materials in Medicine, Vol. 21, No. 1, 2010, pp. 207-214. doi:10.1007/s10856-009-3835-9
|
[24]
|
M. Prokopowicz, “Silica-Polyethylene Glycol Matrix Synthesis by Sol-Gel Method and Evaluation for Diclofenac Diethylammonium Release,” Drug Delivery, Vol. 14, 2007, pp. 129-138.
|
[25]
|
J. H. Park, G. Saravanakumar, K. Kim and I. C. Kwon, “Targeted Delivery of Low Molecular Drugs Using Chitosan and Its Derivatives,” Advanced Drug Delivery Reviews, Vol. 62, No. 1, 2010, pp. 28-41.
doi:10.1016/j.addr.2009.10.003
|
[26]
|
M. Dash, F. Chiellini, R. M. Ottenbrite and E. Chiellinial, “Chitosan: A Versatile Semi-Synthetic Polymer in Biomedical Applications,” Progress in Polymer Science, Vol. 36, No. 8, 2011, pp. 981-1014.
doi:10.1016/j.progpolymsci.2011.02.001
|
[27]
|
I. Rashid, M. Al-Remawi, A. Eftaiha and A. Badwan, “Chitin-Silicon Dioxide Coprecipitate as a Novel Super Disintegrant,” Journal of Pharmaceutical Sciences, Vol. 97, No. 11, 2008, pp. 4955-4969. doi:10.1002/jps.21354
|
[28]
|
Y. M. Bolbukh, P. O. Kuzema, V. A. Tertykh and B. Gawdzik, “Effect of Surface Hydride, Vinyl, and Methyl Groups on Thermal Stability of Modified Silica-Divinylbenzene-Di(methacryloyloxymethyl)naphthalene Composites,” International Journal of Polymeric Materials and Polymeric Biomaterials, Vol. 56, No. 3, 2007, pp. 803-823. doi:10.1080/00914030601163464
|
[29]
|
R. B. Kozakevych, Y. M. Bolbukh and V. A. Tertykh, “Desorption of Diclofenac Sodium from Silica-Chitosan Composites,” Pharmaceutical Journal, Vol. 3, 2009, pp. 103-111.
|
[30]
|
K. V. Katok, Y. Bolbukh and V. A. Tertykh, “Chemical Modification of Silica Surface by Immobilization of Amino Groups for Synthesis of Silver Nanoparticles, NATO Science Series II. Mathematics, Physics and Chemistry,” In: M. Vaclavikova, K. Vitale, G. Gallios and L. Ivanicova, Eds., Water Treatment Technologies for Removal of High-Toxicity Pollutants, Springer, New York, 2009, pp. 283-287. doi:10.1007/978-90-481-3497-7_29
|
[31]
|
V. L. Gonçalves, M. C. M. Laranjeira, V. T. Fávere and R. C. Pedrosa, “Effect of Crosslinking Agent on Chitosan Microsheres in Controlled Release of Diclofenac Sodium,” Polímeros, Vol. 15, No. 1, 2005, pp. 6-12.
doi:10.1590/S0104-14282005000100005
|
[32]
|
F. Pati, B. Adhikari and S. Dhara, “Development of Chitosan-Tripolyphosphate Fibers through pH-Dependent Ionotropic Gelation,” Carbohydrate Research, Vol. 346, No. 16, 2011, pp. 2582-2588.
doi:10.1016/j.carres.2011.08.028
|
[33]
|
Ukrainian State Pharmacopoeia, “REREIG,” Kharkiv, Ukraine, 2001.
|
[34]
|
J. C. McElnay and A. C. Nicol, “The Comparison of a Novel Continuous-Flow Dissolution Apparatus for Suppositories with the Rotating Basket Technique,” International Journal of Pharmaceutics, Vol. 19, No. 1, 1984, pp. 89-96. doi:10.1016/0378-5173(84)90135-2
|
[35]
|
I. M. Kenawi, B. N. Barsoum and M. A. Youssef, “Cetirizine Dihydrochloride Interaction with Some Diclofenac Complexes,” European Journal of Pharmaceutical Sciences, Vol. 26, No. 3-4, 2005, pp. 341-348.
doi:10.1016/j.ejps.2005.07.007
|
[36]
|
M. L. Manca, M. Zaru, G. Ennas, D. Valenti, C. Sinico, G. Loy and A. M. Fadda, “Diclofenac-β-Cyclodextrin Binary Systems: Physicochemical Characterization and in Vitro Dissolution and Diffusion Studies,” AAPS PharmSciTech, Vol. 6, No. 3, 2005, pp. 464-472. doi:10.1208/pt060358
|
[37]
|
J. Siepmann and F. Siepmann, “Mathematical Modeling of Drug Delivery,” International Journal of Pharmaceutics, Vol. 364, No. 2, 2008, pp. 328-343.
doi:10.1016/j.ijpharm.2008.09.004
|
[38]
|
S. Dash, P. N. Murthy, L. Nath and P. Chowdhur, “Kinetic Modeling on Drug Release from Controlled Drug Delivery Systems,” Acta Poloniae Pharmaceutic, Vol. 67, 2010, pp. 217-223.
|